Investors Face Deadline in Microvast Securities Fraud Lawsuit

The complaint filed by Wolf Haldenstein Adler Freeman & Herz LLP centers on the period between April 1, 2025, and March 16, 2026. Plaintiffs contend that Microvast management misled shareholders by overstating their ability to meet margin targets and misrepresenting the timeline for the Huzhou Phase 3.2 expansion. Allegations suggest that inventory management failures and delays in customer rollouts were systematically downplayed to maintain investor confidence.

Market skepticism began surfacing in June 2025 following a report from Grizzly Research, which accused the company of fabricating production capabilities and overstating economic prospects. Subsequent events, including the rapid departure of CFO Charles Schultz and consistent failures to hit projected expansion milestones, triggered multiple sharp declines in the stock price. By the time Microvast reported its year-end results in March 2026—revealing a gross margin collapse to 1% and a significant revenue miss—the stock had plummeted to $1.52 per share. Investors seeking to participate in the case are encouraged to contact the firm before the September deadline.